The Weekly Update | Week of April 20th

🔗 view.message.yale.edu?vawpToken=AJ...

Starting soon! Join us for Addiction Medicine Grand Rounds with guest speakers, Julia Rozanova, PhD, and Sir John Strang, MBBS.

medicine.yale.edu/internal-med...

The Weekly Update | Week of April 13

🔗 view.message.yale.edu?vawpToken=2H...

How the insurance system quietly undoes recovery from addiction People who have been stable for years are suddenly re-exposed to risk — not because their disease worsened, but because their coverage did.

"In addiction care, stability is fragile because the systems supporting patients are weak." In a new piece for @statnews.com, Yale Addiction Medicine Fellow, John Fomeche, MD, discusses how health insurance systems threaten recovery. www.statnews.com/2026/04/07/a...

The Weekly Update | Week of April 6, 2026

🔗 view.message.yale.edu?vawpToken=AC...

SB 365: Put Buprenorphine in emergency departments I wish we didn't need a law to get doctors to treat opioid use disorder like any other emergency, But this bill is a step in the right direction.

In a newly published op-ed for @ctmirror.org, Dr. Cara Borelli discusses SB365, which would require Connecticut emergency departments to offer buprenorphine to patients with opioid use disorder. ctmirror.org/2026/03/31/s...

The Weekly Update | Week of March 30th

🔗 view.message.yale.edu?vawpToken=KT...

The Weekly Update | Week of March 24th

🔗 view.message.yale.edu?vawpToken=VT...

AI Gave My Patient Dangerous Medical Advice. Here's The Simple Question I Wish All Doctors Would Ask. "Patients and doctors need a nuanced take on the risks and benefits of using AI."

In a new op-ed for @huffpost.com, Dr. Cara Borelli discusses navigating patients' use of AI for medical advice in the context of addiction care and beyond. www.huffpost.com/entry/doctor...

Caregiving in the Shadow of Substance Use​ How to navigate the emotional and practical tolls of caring for a loved one with a drug or alcohol addiction

“SUDs aren’t just a problem for younger adults, they are rising among older Americans, and caregivers need to understand that addiction is a medical disease, not a moral failing” shares Dr. Melissa Weimer. "Silence shuts the door to support." Read more: www.aarp.org/caregiving/b...

The Weekly Update | Week of March 16th

🔗 view.message.yale.edu?vawpToken=42...

Recent federal policy shifts may impact access to + practice of evidence-based addiction care. Tomorrow, join us for Addiction Medicine Rounds with Kelly Corredor, JD (ASAM) to characterize these changes and explore effective advocacy strategies.

medicine.yale.edu/event/addict...

Starting soon! Join us for Addiction Medicine Grand Rounds today with Ismene Petrakis, MD.

medicine.yale.edu/internal-med...

The Weekly Update | Week of March 9th

🔗 view.message.yale.edu?vawpToken=OO...

Integrating Tobacco Treatment in HIV Care Yale School of Medicine's E. Jennifer Edelman, MD, MHS, tested an adaptive, team-based strategy to better integrate tobacco treatment into HIV clinics.

A new study from E. Jen Edelman et al tested an adaptive, team-based strategy to better integrate tobacco treatment into HIV clinics. Says Edelman, smoking must become a higher priority in HIV care + novel strategies can help patients live longer, healthier lives. medicine.yale.edu/internal-med...

Wonderful to see so many join us live for today's Addiction Medicine Grand Rounds on MOUD in pregnancy! Join us again, next week, when we'll be hearing from Yale Psychiatry's Ismene Petrakis, MD on PTSD in the setting of SUD treatment.

medicine.yale.edu/event/addict...

The Weekly Update | Week of March 2nd

🔗 view.message.yale.edu?vawpToken=XY...

Thanks to all 100+ of you who joined us for Addiction Medicine Grand Rounds, yesterday! We'll be back next week with a session on MOUD in pregnancy. Details @ the link below:

medicine.yale.edu/internal-med...

Curious about GLP-1s for substance use disorder treatment? Join us, tomorrow, for Addiction Medicine Grand Rounds with guest speaker, Dr. Joji Suzuki (@harvardmed.bsky.social).

🔗 medicine.yale.edu/internal-med...

The Weekly Update | Week of February 23rd

🔗 view.message.yale.edu?vawpToken=LU...

The Weekly Update | Week of February 16th

🔗 view.message.yale.edu?vawpToken=ED...

Emergency Department–Initiated Buprenorphine for Opioid Use Disorder This randomized clinical trial assesses the effect of emergency department (ED)–initiated 7-day extended-release injectable buprenorphine vs sublingual buprenorphine on treatment engagement at 7 days ...

(2/2) Read the full manuscript here: jamanetwork.com/journals/jam...

(1/2) A new study in @jama.com from @gaildonofrio.bsky.social et al found that 7-day injectable buprenorphine and daily tablet buprenorphine are equally safe and effective in engaging patients with opioid use disorder in treatment after an emergency department visit.

news.yale.edu/2026/02/11/s...

Thanks, all, who joined us for addiction medicine grand rounds, yesterday! We'll be back 2/24 with guest speaker, Dr. Joji Suzuki (@harvardmed.bsky.social), who will be speaking on GLP-1s. Hope to see you there!

medicine.yale.edu/event/addict...

Join us, today, at 12pm EST for Addiction Medicine Grand Rounds with @rnbluthenthal.bsky.social & Sid Ganesh (@keck.usc.edu, @uscpphs.bsky.social). Register @ the link below.

medicine.yale.edu/internal-med...

The Weekly Update | Week of February 9th

🔗 view.message.yale.edu?vawpToken=VH...

Moderate Drinking: What Are the Benefits and Risks? Studies have shown that moderate drinking can impact health in numerous ways. So is it safe or not? Experts weigh in.

Recent research on alcohol’s effect on heart disease, cancer, & the brain has prompted changes from major health organizations + societies. If you’re fuzzy on how to drink responsibly, that's understandable. Dr. Steve Holt (@YaleIMed) & others weigh in: www.everydayhealth.com/diet-nutriti...

Methadone: Public Transit is a Barrier for Accessing Treatment In a new study published in JAMA Network Open, Yale researchers examined the burdens for people who use public transit to access methadone treatment for opioid

New in @jamanetworkopen.com, @howellben.bsky.social et al highlight notable disparities in public transit access to #methadone treatment for OUD in Connecticut.
medicine.yale.edu/internal-med...

@gregggonsalves.bsky.social @emmabiegacki.bsky.social @yalesph.bsky.social @yaleschoolofmed.bsky.social

The Weekly Update | Week of February 3rd

🔗 view.message.yale.edu?vawpToken=XT...

National Methadone Access and Quality Commission Established to Improve Access To High-Quality, Patient-Centered, Evidence-Based Treatment for OUD - FORE FORE has awarded a grant of $917,027 to Yale University to establish the National Methadone Access and Quality Commission (NMAQC), a new national initiative focused on improving access to methadone, a...

The Foundation for Opioid Response Efforts has awarded a grant to Yale University to establish the National Methadone Access and Quality Commission, a new national initiative focused on improving access to methadone for the treatment of opioid use disorder. Read more: forefdn.org/national-met...